Advertisement

Magnesium after Renal Transplantation — Comparison between Cyclosporine A and Conventional Immunosuppression

  • Wilhelm Kaiser
  • Georg Biesenbach
  • Engelbert Kramer
  • Jan Zazgornik
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 252)

Abstract

Neurotoxicity and hypertension are typical side-effects of cyclosporine A. In bone-marrow transplantation using 1 cyclosporine A for immunosuppression the onset of neurotoxicity2 and hypertension2 had been correlated with hypomagnesemia. We therefore studied the differences in serum magnesium and urinary magnesium excretion in both cyclosporine and azathioprine/prednisone immunosuppressed renal transplant patients, respectively.

Keywords

Fractional Excretion Graft Function Renal Transplant Patient Magnesium Level Serum Magnesium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B. C. Thompson, K. M. Sullivan, H. C. June, E. D. Thomas, Association between cyclosporine neurotoxicity and hypomagnesemia. Lancet 11:1116 (1984).CrossRefGoogle Scholar
  2. 2.
    C. H. June, C. B. Thompson, M. S. Kennedy, T. P. Loughran, H. J. Deeg, Correlation of hypomagnesemia with the onset of cyclosporine- associated hypertension in marrow transplant patients. Transplantation 41 (1):47 (1986)PubMedCrossRefGoogle Scholar
  3. 3.
    C. H. June, C. B. Thompson, M. S. Kennedy, J. Nims, E. D. Thomas, Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplsintation 39 (6):620 (1985).CrossRefGoogle Scholar
  4. 4.
    A. G. Palestine, H. A. Austin, R. B. Nussenblatt, Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis. Transplant. Proc. 17 (4), Suppl. 1:209 (1985).Google Scholar
  5. 5.
    D. C. Battle, M. F. Mozes, J. Manaligod, A. L. Arruda, N. A. Kurtzman, The pathogenesis of hyperchloremic metaibolic acidosis associated with kidney transplantation. Am. J. Med. 70:786 (1981).CrossRefGoogle Scholar
  6. 6.
    R. A. De Fronzo, M. Goldberg, C. R. Cooke, C. Barker, R. A. Grossman, Z. Agus, Investigations into the mechanism of hyperkalemia following renal transplantation. Kidney Int. 11:357 (1977).CrossRefGoogle Scholar
  7. 7.
    S. N. Chatterjee, R. M. Friedler, T. V. Berne, S. B. Oldham, F. R. Singer, S. G. Massry, Persistent hypercalcemia after successful renal transplantation. Nephron 17:1 (1971).CrossRefGoogle Scholar
  8. 8.
    J. Zazgornik, F. Kokot, K. Fürst, P. Schmidt, J. Pietrek, H. Czembirek, H. Kopsa, P. Balcke, Elisabeth Paietta, Roentgenologic soft tissue and bone changes, parathyroid-hormone, 25-hydroxy- cholecalciferol, calcium-phosphorus concentrations in serum in dialyzed and renal transplant patients. Dialysis &. Transplantation 8:389 (1979).Google Scholar
  9. 9.
    M. G. Bachem, B. Köhler, H. Bauer, B. Zanker, H. E. Franz, E. F. Pfeiffer, Cyclosporin A bedingter Magnesiummangel nach Nierentransplantation. Klin. Wochenschr. 64 (Suppl. V): 202 (1986).Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Wilhelm Kaiser
    • 1
  • Georg Biesenbach
    • 1
  • Engelbert Kramer
    • 1
  • Jan Zazgornik
    • 1
  1. 1.II Medical DepartmentGeneral Hospital of LinzLinzAustria

Personalised recommendations